| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Ballou-Aares Daniella | Director | C/O IBEX LIMITED, 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON | Lisa Lenstrohm, Attorney-in-Fact | 30 Dec 2025 | 0001973685 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IBEX | Common Shares | Options Exercise | $39,254 | +2,066 | +16% | $19.00 | 15,060 | 30 Dec 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IBEX | Stock Option (Right to Buy Common Shares) | Options Exercise | $39,254 | -2,066 | -100% | $19.00 | 0 | 30 Dec 2025 | Common Shares | 2,066 | $19.00 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Transaction to exercise options was submitted by Reporting Person on November 22, 2025, with payment received and shares released by the Issuer on December 30, 2025. |
| F2 | The shares subject to this option are fully vested and exercisable. |